An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.
HGG Adv
; 3(4): 100138, 2022 Oct 13.
Article
in En
| MEDLINE
| ID: mdl-36119806
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
HGG Adv
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos